Pharmaceutical

Canada and Alberta governments to invest in Entos R&D facility

Entos Pharmaceuticals has announced an investment of C$62m ($43.05m) from the governments of Canada and Alberta for an R&D facility.

Mar 13, 2025 - 06:00
Canada and Alberta governments to invest in Entos R&D facility
Entos Pharmaceuticals has announced an investment of C$62m ($43.05m) from the governments of Canada and Alberta for an R&D facility.
Read the original article

Tags:

Previous Article

Zealand and Roche strike $5.3bn obesity treatment deal

Next Article

WuXi XDC and AbTis collaborate on antibody-drug conjugates

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Astellas licenses 4DMT’s AAV vector for ophthalmic targets

Astellas licenses 4DMT’s AAV vector for ophthalmic targets

Jul 11, 2023

FDA grants breakthrough therapy status to Arrowhead’s plozasiran

FDA grants breakthrough therapy status to Arrowhead’s p...

Sep 12, 2024

STAT+: How the FDA’s pandemic flexibilities boosted mental health apps — and what happens now

STAT+: How the FDA’s pandemic flexibilities boosted men...

May 11, 2023